Remove Embolism Remove Medicare Remove Strokes
article thumbnail

Abstract TP328: The Association between Post-ICH Continuation of Statin Use and Major Adverse Cardiovascular Events

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP328-ATP328, February 1, 2025. We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Objective:The role of statins in the management of intracerebral hemorrhage (ICH) remains controversial. 72-86] years; 57.0%

article thumbnail

Potential Risk of Serious Bleeding in Patients With AF Using Diltiazem With Apixaban or Rivaroxaban

All About Cardiovascular System and Disorders

A potentially serious drug interaction between diltiazem and apixaban or rivaroxaban has been reported in US Medicare patients taking these drugs together for atrial fibrillation. It was a retrospective cohort study which included US Medicare benefiaries aged 65 years or more with atrial fibrillation and follow up period was one year.

article thumbnail

Abstract TMP78: Disparities in Experiencing Major Adverse Cardiovascular Events Among Survivors of Spontaneous Intracerebral Hemorrhage by Hematoma Location

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page ATMP78-ATMP78, February 1, 2024. Medicare) have a lower risk of r-ICH (0.45, 0.31 - 0.67), AIS (0.71, 0.53 - 0.95), and MACE (0.58, 0.47 - 0.71). Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% Patients with lobar ICH (vs. Blacks (vs.